EFTR (eFFECTOR Therapeutics) OCF Margin %: 0.00% (As of Mar. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is eFFECTOR Therapeutics OCF Margin %?

eFFECTOR Therapeutics EFTR OCF Margin % is 0.00% as of Mar. 2024.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. eFFECTOR Therapeutics's Cash Flow from Operations for the three months ended in Mar. 2024 was $-7.28 Mil. eFFECTOR Therapeutics's Revenue for the three months ended in Mar. 2024 was $0.00 Mil. Therefore, eFFECTOR Therapeutics's OCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, eFFECTOR Therapeutics's current OCF Yield % is -2,919,100.00%.

The historical rank and industry rank for eFFECTOR Therapeutics's OCF Margin % or its related term are showing as below:


EFTR's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -68.59
* Ranked among companies with meaningful OCF Margin % only.

eFFECTOR Therapeutics OCF Margin % Related Terms

eFFECTOR Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for eFFECTOR Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

eFFECTOR Therapeutics OCF Margin % Chart

eFFECTOR Therapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
OCF Margin %
32.94 0.00 0.00 0.00

eFFECTOR Therapeutics Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

eFFECTOR Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

eFFECTOR Therapeutics's OCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-29.55/0
= %

eFFECTOR Therapeutics's OCF Margin for the quarter that ended in Mar. 2024 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-7.278/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
eFFECTOR Therapeutics (EFTR) has a OCF Margin % of 0.00% as of Mar. 2024. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on eFFECTOR Therapeutics and its competitors.
Is eFFECTOR Therapeutics' OCF Margin % too high?
eFFECTOR Therapeutics' current OCF Margin % is 0.00%.
How does eFFECTOR Therapeutics' OCF Margin % compare to NTBLQ and MTEM?
eFFECTOR Therapeutics' OCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on eFFECTOR Therapeutics and its competitors. eFFECTOR Therapeutics's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is eFFECTOR Therapeutics stock overvalued right now?
eFFECTOR Therapeutics (EFTR) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For eFFECTOR Therapeutics (EFTR), the current OCF Margin % is 0.00% as of Mar. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

eFFECTOR Therapeutics Business Description

Address 142 North Cedros Avenue, Suite B, Solana Beach, CA, USA, 92075
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).